Controlling shareholder Zhou Zhiwen of Joinn Laboratories (06127) has accumulated a reduction of 14.979 million A shares.

Joinn Laboratories (06127) announced that one of the actual controllers of the company, Zhou Zhiwen, disclosed a reduction plan on December 30, 2025. Within 3 months after the announcement of the reduction plan and 15 trading days, Zhou Zhiwen planned to reduce no more than 14.98 million shares through the Shanghai Stock Exchange's centralized bidding or block trading methods, not exceeding 20.0466% of his holdings and 1.99873% of the company's total share capital at the time. As of January 29, 2026, Zhou Zhiwen had reduced the company's A-shares by 14.979 million shares through block trading and centralized bidding methods, and decided to terminate the reduction plan early.